![Julian Gilbert](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Julian Gilbert
Vorsitzender bei
River Biomedics B V I.O.
Vermögen: 52 688 $ am 31.08.2026
Profil
Julian Clive Gilbert was the founder of Sosei R&D Ltd. (founded in 2000) and served as Commercial Director.
Dr. Gilbert was the founder of Acacia Pharma Ltd. (founded in 2006) and served as Chief Executive Officer from 2006 to 2012.
Dr. Gilbert was the founder of Acacia Pharma Group Ltd. (founded in 2007) and served as Chief Executive Officer & Director from 2007 to 2019.
Dr. Gilbert is currently Chairman at River Biomedics B V I.O.
since 2022.
Dr. Gilbert is currently Director at Nuformix Technologies Ltd. since 2022.
Dr. Gilbert is currently Non-Executive Director at Exvastat Ltd. Dr. Gilbert is currently Non-Executive Director at Monument Therapeutics Ltd. since 2021.
Former positions include Non-Executive Chairman at Nuformix Plc from 2022 to 2026, Non-Executive Director at IOTA NanoSolutions Ltd., Manager-Business Development at Mundipharma International Ltd., Licensing Executive at BTG Ltd., Head-Formulation Development at Smith Kline & French Laboratories Ltd., and Head-Licensing at Chiroscience Ltd. Education includes undergraduate and doctorate degrees from The University of Nottingham.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NUFORMIX PLC 0,9 % | 11.11.2025 | 23.521.428 ( 0,9 % ) | 52 688 $ | 31.08.2026 |
Aktive Positionen von Julian Gilbert
| Unternehmen | Position | Beginn |
|---|---|---|
Monument Therapeutics Ltd.
 Monument Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops precision medicines for central nervous system | Direktor/Vorstandsmitglied | 01.08.2021 |
Exvastat Ltd.
 Exvastat Ltd. Pharmaceuticals: MajorHealth Technology Operates as a preclinical-stage pharmaceutical company which develops a treatment for acute respiratory distress syndrome | Direktor/Vorstandsmitglied | - |
River Biomedics B V I.O.
 River Biomedics B V I.O. Medical SpecialtiesHealth Technology Develops in vitro 3D human heart tissue for pre-clinical drug testing models | Vorsitzender | 01.03.2022 |
Nuformix Technologies Ltd.
 Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Julian Gilbert
| Unternehmen | Position | Ende |
|---|---|---|
| NUFORMIX PLC | Vorsitzender | 31.08.2026 |
| ACACIA PHARMA GROUP PLC | Gründer | 31.07.2019 |
IOTA NanoSolutions Ltd.
 IOTA NanoSolutions Ltd. Chemicals: Major DiversifiedProcess Industries Develops organic nanoparticles | Direktor/Vorstandsmitglied | 10.10.2013 |
Smith Kline & French Laboratories Ltd.
 Smith Kline & French Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Mundipharma International Ltd.
 Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Develops and produces pharmaceutical products | Corporate Officer/Principal | - |
Ausbildung von Julian Gilbert
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
32
Beziehungen ersten Grades
14
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 14 |
|---|---|
Mundipharma International Ltd.
Mundipharma International Ltd. Pharmaceuticals: MajorHealth Technology Develops and produces pharmaceutical products | Health Technology |
BTG Ltd.
 BTG Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and supplies drugs used in the treatment of neurological disorders | Health Technology |
Sosei R&D Ltd.
 Sosei R&D Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
The University of Nottingham
 The University of Nottingham Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Acacia Pharma Ltd.
 Acacia Pharma Ltd. Pharmaceuticals: MajorHealth Technology Provides supportive care product opportunities for post-surgical and cancer patients | Health Technology |
IOTA NanoSolutions Ltd.
IOTA NanoSolutions Ltd. Chemicals: Major DiversifiedProcess Industries Develops organic nanoparticles | Process Industries |
Smith Kline & French Laboratories Ltd.
Smith Kline & French Laboratories Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Chiroscience Ltd. | |
Nuformix Technologies Ltd.
Nuformix Technologies Ltd. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Acacia Pharma Group Ltd.
 Acacia Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Operates as a holding company that engages in developing and commercializing novel products for surgery, invasive procedures & chemotherapy | Health Technology |
Exvastat Ltd.
Exvastat Ltd. Pharmaceuticals: MajorHealth Technology Operates as a preclinical-stage pharmaceutical company which develops a treatment for acute respiratory distress syndrome | Health Technology |
Nuformix Plc
 Nuformix Plc BiotechnologyHealth Technology Develops commercial technologies in pharmaceutical and biotechnology sector | Health Technology |
River Biomedics B V I.O.
River Biomedics B V I.O. Medical SpecialtiesHealth Technology Develops in vitro 3D human heart tissue for pre-clinical drug testing models | Health Technology |
Monument Therapeutics Ltd.
Monument Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops precision medicines for central nervous system | Health Technology |
